10x Genomics Appoints Ansuman Satpathy, Joseph Gilliam to Board

PUBT · 1d ago
10x Genomics Appoints Ansuman Satpathy, Joseph Gilliam to Board
  • 10x Genomics appointed Ansuman Satpathy and Joseph Gilliam as Class III directors on October 28, 2026, effective immediately.
  • Their terms run through the 2028 annual shareholder meeting.
  • Gilliam was named chair of the board’s Audit Committee on October 30, 2026.
  • Satpathy is a Stanford pathology and immunology associate professor, life sciences entrepreneur and former scientific adviser to the company.
  • Gilliam is Glaukos’ president and chief operating officer, previously serving as its chief financial officer and a JPMorgan healthcare investment banking managing director.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-068867), on November 02, 2026, and is solely responsible for the information contained therein.